To Curb Coronavirus, What’s Behind The Wearing Of A Mask?

The Centers for Disease Control and Prevention on Friday recommended wearing cloth face masks when going out, especially to places like grocery stores and pharmacies.

Source: khn.org

That’s because a “significant portion” of people with the virus lack symptoms or can transmit the disease through close contact before they show signs of illness, the CDC said. It is not recommending people try to purchase N95 or surgical masks, and the federal agency included online instructions on making masks out of materials at home.

The recommendation is optional. President Donald Trump, for instance, said he didn’t envision wearing one. But in recent days, the number of people sporting some type of protective face gear appears to have soared.

So what gives?

Many experts agree that wearing a mask probably won’t keep people from getting the coronavirus, but it might help prevent those with the disease — especially those without symptoms ― from spreading it.

The CDC’s announcement — which came after days of deliberation among White House officials, the coronavirus task force and other public health figures about the need for such a guideline — brings with it caution.

First, masks could give people a false sense of security.

“We don’t want people to feel like, ‘Oh, I’m wearing a mask. I’m protected and I’m protecting others,’” said Dr. Deborah Birx, during a White House briefing last week before the CDC issued its recommendation. Birx, a member of the president’s coronavirus task force, made clear that wearing a mask would not replace the need for frequent hand-washing and continued social distancing.

Another concern is that the recommendation could further strain the supply of medical-grade masks for health care workers, if consumers flooded the market to get their hands on one. Earlier statements from U.S. officials downplayed the use of face masks in public, in part for this reason.

But those messages ran counter to what other countries ― particularly in Asia — have recommended or required. Face masks have been ubiquitous in countries such as China, South Korea and Japan during the outbreak.

Before the CDC recommendation, residents in some hard-hit American cities, such as Los Angeles and New York, were encouraged to wear masks in public. Riverside County in Southern California mandated it.

Another issue: Homemade masks — and some store-bought ones ― don’t fit as tightly as medical masks.

“Virus can sneak around the edges,” said Melissa Perry, a professor of environmental and occupational health at George Washington University in Washington, D.C.

There’s also the matter of the fabric.

“What I see are people buying masks on the web that are fashionable, but the fabric is thin,” said John Lednicky, an aerovirologist at the University of Florida, who studies how viruses spread through the air. “If the weave is not tight enough, the virus will go right through them.”

Still, he said, a homemade mask “is better than nothing” if it could block some particles expelled by an infected person. But he cautioned that a mask protects only the nose and mouth areas. Another route of transmission is through the eyes. So, again, don’t touch your face or rub your eyes if possible.

Might eyeglasses add protection from particles?

“There’s some protection from eyeglasses, but there’s a lot of space around eyeglasses, so air currents can still hit your eyes,” he said.

And one more caution: “When putting it on and taking it off, you have to be careful. You might end up getting virus all over your hands,” said Marcus Plescia, chief medical officer with the Association of State and Territorial Health Officials. “Discard it carefully.”

If it’s made of fabric, wash it. If it’s paper or some other material, put it in a sealed plastic bag and throw it away. Wash your hands after.

Transmission Out Of Thin Air?

Researchers are debating whether simply talking or breathing can send tiny virus particles airborne ― and whether those bits would be in great enough quantity to allow for transmission to another person.

This critical question has no clear answer.

No doubt a cough or sneeze can shoot out droplets several feet, but those are relatively large and heavy and quickly fall to the ground, researchers say. Still, that’s a main route of transmission because the droplets can either land on a close contact — defined by the World Health Organization as within 1 meter ― or fall on surfaces, which other people then touch, possibly picking up the virus.

Staying 6 feet away from others and washing your hands a lot helps reduce the risk packed by droplets.

But what about smaller particles — those aerosols created simply by exhaling that can float in the air longer?

Evidence is not clear.

A special panel last week released a report reviewing studies from the U.S. and China, raising the possibility of airborne transmission. The studies’ findings suggest that normal breathing can release aerosolized virus, according to the letter from a special pandemic committee at the National Academy of Sciences to the head of the White House’s Office of Science and Technology Policy.

But, the committee added, “one must be cautious,” because what the studies found may not represent “viable virus in sufficient amounts to produce infection.”

The WHO, in a March 20 report, took a more cautious approach, saying there isn’t enough information to say such tiny particles are airborne outside of medical settings.

Aerosols containing the virus can occur during some medical procedures, such as ventilating a patient, the WHO said, which puts health care workers at risk. Further study is needed, the report concluded, to see if the virus shows up in air samples in patient rooms where no such procedures took place and “whether viable virus is found and what role it may play in transmission.”

Given the uncertainty, the bottom line, Lednicky and others said, is to avoid close contact and take other reasonable protective steps.

Masks are good to ensure that you are not transmitting the virus to others. But don’t forget about that 6-foot zone of personal space.

How Does This Translate To Everyday Life?

Experts agree that in the midst of this pandemic ― while people are encouraged to stay at home and isolate — it’s still important for physical and mental health to get exercise by walking or running. But what happens when you cross paths with another person, who may not be wearing a mask?

“More distance is better no matter what,” said Dr. Georges Benjamin, executive director of the American Public Health Association, who said there is only a small likelihood that you are running through a mist that might contain the virus.

“If you want to hold your breath [while passing near others], fine, but it’s probably not necessary,” he said.

And then there’s your neighbor’s friendly dog. Researchers don’t believe pets can transmit the disease. Still, to protect the pet, they suggest that those who are sick to avoid caring for or sharing their food with the animal, said Benjamin. Because keeping a proper distance from your neighbor is also key, it might be a good idea to skip the dog-petting.

“I would just say ‘Hi’ right now,” said Benjamin.

Overall, most health officials appear to consider masks a good idea. But they agree on three constants in this quickly changing matter: Keep your distance from others outside your household. Wash your hands ― often. And don’t touch your face.

Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020

Globally, approximately 170,000 confirmed cases of coronavirus disease 2019 (COVID-19) caused by the 2019 novel coronavirus (SARS-CoV-2) have been reported, including an estimated 7,000 deaths in approximately 150 countries (1). On March 11, 2020, the World Health Organization declared the COVID-19 outbreak a pandemic (2). Data from China have indicated that older adults, particularly those with serious underlying health conditions, are at higher risk for severe COVID-19–associated illness and death than are younger persons (3). Although the majority of reported COVID-19 cases in China were mild (81%), approximately 80% of deaths occurred among adults aged ≥60 years; only one (0.1%) death occurred in a person aged ≤19 years (3). In this report, COVID-19 cases in the United States that occurred during February 12–March 16, 2020 and severity of disease (hospitalization, admission to intensive care unit [ICU], and death) were analyzed by age group. As of March 16, a total of 4,226 COVID-19 cases in the United States had been reported to CDC, with multiple cases reported among older adults living in long-term care facilities (4). Overall, 31% of cases, 45% of hospitalizations, 53% of ICU admissions, and 80% of deaths associated with COVID-19 were among adults aged ≥65 years with the highest percentage of severe outcomes among persons aged ≥85 years. In contrast, no ICU admissions or deaths were reported among persons aged ≤19 years. Similar to reports from other countries, this finding suggests that the risk for serious disease and death from COVID-19 is higher in older age groups.

Data from cases reported from 49 states, the District of Columbia, and three U.S. territories (5) to CDC during February 12–March 16 were analyzed. Cases among persons repatriated to the United States from Wuhan, China and from Japan (including patients repatriated from cruise ships) were excluded. States and jurisdictions voluntarily reported data on laboratory-confirmed cases of COVID-19 using previously developed data collection forms (6). The cases described in this report include both COVID-19 cases confirmed by state or local public health laboratories as well as those with a positive test at the state or local public health laboratories and confirmation at CDC. No data on serious underlying health conditions were available. Data on these cases are preliminary and are missing for some key characteristics of interest, including hospitalization status (1,514), ICU admission (2,253), death (2,001), and age (386). Because of these missing data, the percentages of hospitalizations, ICU admissions, and deaths (case-fatality percentages) were estimated as a range. The lower bound of these percentages was estimated by using all cases within each age group as denominators. The corresponding upper bound of these percentages was estimated by using only cases with known information on each outcome as denominators.

As of March 16, a total of 4,226 COVID-19 cases had been reported in the United States, with reports increasing to 500 or more cases per day beginning March 14 (Figure 1). Among 2,449 patients with known age, 6% were aged ≥85, 25% were aged 65–84 years, 18% each were aged 55–64 years and 45–54 years, and 29% were aged 20–44 years (Figure 2). Only 5% of cases occurred in persons aged 0–19 years.

Among 508 (12%) patients known to have been hospitalized, 9% were aged ≥85 years, 36% were aged 65–84 years, 17% were aged 55–64 years, 18% were 45–54 years, and 20% were aged 20–44 years. Less than 1% of hospitalizations were among persons aged ≤19 years (Figure 2). The percentage of persons hospitalized increased with age, from 2%–3% among persons aged ≤19 years, to ≥31% among adults aged ≥85 years. (Table).

Among 121 patients known to have been admitted to an ICU, 7% of cases were reported among adults ≥85 years, 46% among adults aged 65–84 years, 36% among adults aged 45–64 years, and 12% among adults aged 20–44 years (Figure 2). No ICU admissions were reported among persons aged ≤19 years. Percentages of ICU admissions were lowest among adults aged 20–44 years (2%–4%) and highest among adults aged 75–84 years (11%–31%) (Table).

Among 44 cases with known outcome, 15 (34%) deaths were reported among adults aged ≥85 years, 20 (46%) among adults aged 65–84 years, and nine (20%) among adults aged 20–64 years. Case-fatality percentages increased with increasing age, from no deaths reported among persons aged ≤19 years to highest percentages (10%–27%) among adults aged ≥85 years (Table) (Figure 2).

Discussion

Since February 12, 4,226 COVID-19 cases were reported in the United States; 31% of cases, 45% of hospitalizations, 53% of ICU admissions, and 80% of deaths occurred among adults aged ≥65 years with the highest percentage of severe outcomes among persons aged ≥85 years. These findings are similar to data from China, which indicated >80% of deaths occurred among persons aged ≥60 years (3). These preliminary data also demonstrate that severe illness leading to hospitalization, including ICU admission and death, can occur in adults of any age with COVID-19. In contrast, persons aged ≤19 years appear to have milder COVID-19 illness, with almost no hospitalizations or deaths reported to date in the United States in this age group. Given the spread of COVID-19 in many U.S. communities, CDC continues to update current recommendations and develop new resources and guidance, including for adults aged ≥65 years as well as those involved in their care (7,8).

Approximately 49 million U.S. persons are aged ≥65 years (9), and many of these adults, who are at risk for severe COVID-19–associated illness, might depend on services and support to maintain their health and independence. To prepare for potential COVID-19 illness among persons at high risk, family members and caregivers of older adults should know what medications they are taking and ensure that food and required medical supplies are available. Long-term care facilities should be particularly vigilant to prevent the introduction and spread of COVID-19 (10). In addition, clinicians who care for adults should be aware that COVID-19 can result in severe disease among persons of all ages. Persons with suspected or confirmed COVID-19 should monitor their symptoms and call their provider for guidance if symptoms worsen or seek emergency care for persistent severe symptoms. Additional guidance is available for health care providers on CDC’s website (https://www.cdc.gov/coronavirus/2019-nCoV/hcp/index.html).

This report describes the current epidemiology of COVID-19 in the United States, using preliminary data. The findings in this report are subject to at least five limitations. First, data were missing for key variables of interest. Data on age and outcomes, including hospitalization, ICU admission, and death, were missing for 9%–53% of cases, which likely resulted in an underestimation of these outcomes. Second, further time for follow-up is needed to ascertain outcomes among active cases. Third, the initial approach to testing was to identify patients among those with travel histories or persons with more severe disease, and these data might overestimate the prevalence of severe disease. Fourth, data on other risk factors, including serious underlying health conditions that could increase risk for complications and severe illness, were unavailable at the time of this analysis. Finally, limited testing to date underscores the importance of ongoing surveillance of COVID-19 cases. Additional investigation will increase the understanding about persons who are at risk for severe illness and death from COVID-19 and inform clinical guidance and community-based mitigation measures.*

The risk for serious disease and death in COVID-19 cases among persons in the United States increases with age. Social distancing is recommended for all ages to slow the spread of the virus, protect the health care system, and help protect vulnerable older adults. Further, older adults should maintain adequate supplies of nonperishable foods and at least a 30-day supply of necessary medications, take precautions to keep space between themselves and others, stay away from those who are sick, avoid crowds as much as possible, avoid cruise travel and nonessential air travel, and stay home as much as possible to further reduce the risk of being exposed (7). Persons of all ages and communities can take actions to help slow the spread of COVID-19 and protect older adults.

Acknowledgments

State and local health departments; clinical staff members caring for patients.

CDC COVID-19 Response Team

Stephanie Bialek, CDC; Ellen Boundy, CDC; Virginia Bowen, CDC; Nancy Chow, CDC; Amanda Cohn, CDC; Nicole Dowling, CDC; Sascha Ellington, CDC; Ryan Gierke, CDC; Aron Hall, CDC; Jessica MacNeil, CDC; Priti Patel, CDC; Georgina Peacock, CDC; Tamara Pilishvili, CDC; Hilda Razzaghi, CDC; Nia Reed, CDC; Matthew Ritchey, CDC; Erin Sauber-Schatz, CDC.

Corresponding author: Hilda Razzaghi for the CDC COVID-19 Response Team, HRazzaghi@cdc.gov, 770-488-6518.

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

https://www.cdc.gov/coronavirus/2019-ncov/downloads/community-mitigation-strategy.pdfpdf icon.

 https://www.whitehouse.gov/wp-content/uploads/2020/03/03.16.20_coronavirus-guidance_8.5x11_315PM.pdfpdf iconexternal icon.


References

  1. World Health Organization. Coronavirus disease 2019 (COVID-19) situation report–57. Geneva, Switzerland: World Health Organization; 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200317-sitrep-57-covid-19.pdf?sfvrsn=a26922f2_2pdf iconexternal icon
  2. World Health Organization. Coronavirus disease 2019 (COVID-19) situation report–51. Geneva, Switzerland: World Health Organization; 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10pdf iconexternal icon
  3. Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China [Chinese]. Chinese Center for Disease Control and Prevention Weekly 2020;41:145–51. PubMedexternal icon
  4. CDC. CDC, Washington State report first COVID-19 death [Media statement]. Atlanta, GA: US Department of Health and Human Services, CDC; 2020. https://www.cdc.gov/media/releases/2020/s0229-COVID-19-first-death.html
  5. CDC. Coronavirus disease 2019 (COVID-19): cases in U.S. Atlanta, GA: US Department of Health and Human Services, CDC; 2020. https://www.cdc.gov/coronavirus/2019-ncov/cases-in-us.html
  6. CDC. Coronavirus disease 2019 (COVID-19): information for health departments on reporting a person under investigation (PUI), or presumptive positive and laboratory-confirmed cases of COVID-19. Atlanta, GA: US Department of Health and Human Services, CDC; 2020. https://www.cdc.gov/coronavirus/2019-ncov/php/reporting-pui.html
  7. CDC. Coronavirus disease 2019 (COVID-19): if you are at higher risk. Get ready for COVID-19 now. Atlanta, GA:US Department of Health and Human Services; 2020. https://www.cdc.gov/coronavirus/2019-ncov/specific-groups/high-risk-complications.html
  8. CDC. Coronavirus disease 2019 (COVID-19): schools, workplaces, & community locations. Atlanta, GA: US Department of Health and Human Services, CDC; 2020. https://www.cdc.gov/coronavirus/2019-ncov/community/index.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fpreparing-individuals-communities.html
  9. Administration for Community Living. 2017 profile of older Americans. Washington, DC: US Department of Health and Human Services, Administration for Community Living; 2018. https://acl.gov/sites/default/files/Aging%20and%20Disability%20in%20America/2017OlderAmericansProfile.pdfpdf iconexternal icon
  10. McMichael TM, Clark S, Pogosjans S, et al. COVID-19 in a long-term care facility—King County, Washington, February 27–March 9, 2020. MMWR. Morb Mortal Wkly Rep 2020. Epub March 18, 2020.

This information originally published on CDC.gov

Shipping of CDC 2019 Novel Coronavirus Diagnostic Test Kits Begins

A CDC-developed laboratory test kit to detect 2019 novel coronavirus (2019-nCoV) began shipping yesterday to select qualified U.S. and international laboratories. Distribution of the tests will help improve the global capacity to detect and respond to the 2019 novel coronavirus.

The test kit, called the Centers for Disease Control and Prevention (CDC) 2019-Novel Coronavirus (2019-nCov) Real-Time Reverse Transcriptase (RT)-PCR Diagnostic Panel (CDC 2019-nCoV Real Time RT-PCR), is designed for use with an existing RT-PCR testing instrument that is commonly used to test for seasonal influenza.

The CDC 2019 novel coronavirus test is intended for use with upper and lower respiratory specimens collected from people who meet CDC criteria for 2019-nCoV testing. The test uses a technology that can provide results in four hours from initial sample processing to result.

“Our goal is early detection of new cases and to prevent further spread of the coronavirus,” said CDC Director Robert R. Redfield, M.D. “Distribution of these diagnostic tests to state laboratories, U.S. government partners and more broadly to the global public health community will accelerate efforts to confront this evolving global public health challenge.”

The test kit has not been FDA cleared or approved, however distribution and use of the test kits follows the U.S. Food and Drug Administration (FDA) February 4, 2020, issuance of an Emergency Use Authorizationexternal icon (EUA). The tests are being shipped through the International Reagent Resource (IRR)external icon, a CDC-established mechanism that distributes laboratory reagents domestically and globally.

Initially, about 200 test kits will be distributed to U.S. domestic laboratories and a similar amount will be distributed to select international laboratories. Each test kit can test approximately 700 to 800 patient specimens. Additional test kits will be produced and made available for ordering in the future from the IRR. At this time, each laboratory that places an order will receive one 2019-nCoV test kit.

The IRR is accepting orders for 2019-nCoV tests from qualified laboratories. This includes 115 qualified U.S. laboratories, such as state and local public health laboratories and Department of Defense (DoD) laboratories, as well as 191 qualified international laboratories, such as the World Health Organization (WHO) Global Influenza Surveillance Response System (GISRS) laboratories.

This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of 2019-nCoV under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

Check the CDC website for the latest information and guidance on 2019-nCoV. The CDC will continue to update its guidance as the 2019-nCoV situation evolves.

For additional information, visit CDC 2019 Novel Coronavirus Website: https://www.cdc.gov/coronavirus/

This information originally published on CDC.gov

CDC Confirms Person-to-Person Spread of New Coronavirus in the United States

The Centers for Disease Control and Prevention (CDC) today confirmed that the 2019 Novel Coronavirus (2019-nCoV) has spread between two people in the United States, representing the first instance of person-to-person spread with this new virus here.

Previously, all confirmed U.S. cases had been associated with travel to Wuhan, China, where an outbreak of respiratory illness caused by this novel coronavirus has been ongoing since December 2019. However, this latest 2019-nCoV patient has no history of travel to Wuhan, but shared a household with the patient diagnosed with 2019-nCoV infection on January 21, 2020.

Recognizing early on that the 2019-nCoV could potentially spread between people, CDC has been working closely with state and local partners to identify close contacts of confirmed 2019-nCoV cases. Public health officials identified this Illinois resident through contact tracing. Both patients are in stable condition.

“Given what we’ve seen in China and other countries with the novel coronavirus, CDC experts have expected some person-to-person spread in the US,” said CDC Director Robert R. Redfield, M.D.  “We understand that this may be concerning, but based on what we know now, we still believe the immediate risk to the American public is low.”

Limited person-to-person spread with 2019-nCoV has been seen among close contacts of infected travelers in other countries where imported cases from China have been detected. The full picture of how easily and sustainably the 2019-nCoV spreads is still unclear. Person-to-person spread can happen on a continuum, with some viruses being highly contagious (like measles) and other viruses being less so.

MERS and SARS, the other two coronaviruses that have emerged to cause serious illness in people, have been known to cause some person-to-person spread. With both those viruses, person-to-person spread most often occurred between close contacts, such as healthcare workers and those caring for or living with an infected person. CDC has been proactively preparing for the introduction of 2019-nCoV in the U.S. for weeks, including:

  • First alerting clinicians on January 8 to be on the look-out for patients with respiratory symptoms and a history of travel to Wuhan, China.
  • Developing guidance for preventing 2019 novel coronavirus (2019-nCoV) from spreading to others in homes and communities.
  • Developing guidance for clinicians for testing and management of 2019-nCoV, as well as guidance for infection control of patients hospitalized or being evaluated by a health care provider.

CDC is working closely with Illinois health officials and other local partners. A CDC team has been on the ground since the first 2019-nCoV-positive case was identified and is supporting an ongoing investigation to determine whether further spread with this virus has occurred.

It is likely there will be more cases of 2019-nCoV reported in the U.S. in the coming days and weeks, including more person-to-person spread. CDC will continue to update the public as we learn more about this coronavirus. The best way to prevent infection is to avoid being exposed to this virus. Right now, 2019-nCoV has not been found to be spreading widely in the United States, so CDC deems the immediate risk from this virus to the general public to be low. However, risk is dependent on exposure, and people who are in contact with people with 2019-nCoV are likely to be at greater risk of infection and should take the precautions outlined in CDC’s guidance for preventing spread in homes and communities.

For the general public, no additional precautions are recommended at this time beyond the simple daily precautions that everyone should always take. It is currently flu and respiratory disease season, and CDC recommends getting vaccinated, taking everyday preventive actions to stop the spread of germs, and taking flu antivirals if prescribed. Right now, CDC recommends travelers avoid all nonessential travel to China.

For more information about the current outbreak in China, visit https://www.cdc.gov/coronavirus/2019-ncov/index.html. For travel health information, visit https://wwwnc.cdc.gov/travel/notices/watch/pneumonia-china.

This information was originally published on CDC.gov

Second Travel-related Case of 2019 Novel Coronavirus Detected in United States

The Centers for Disease Control and Prevention (CDC) today confirmed the second infection with 2019 Novel Coronavirus (2019-nCoV) in the United States has been detected in Illinois. The patient recently returned from Wuhan, China, where an outbreak of respiratory illness caused by this novel coronavirus has been ongoing since December 2019.

The patient returned to the U.S. from Wuhan on January 13, 2020, and called a health care provider after experiencing symptoms a few days later.  The patient was admitted to a hospital, where infection control measures were taken to reduce the risk of transmission to other individuals. The patient remains hospitalized in an isolation room in stable condition and is doing well.

Based on the patient’s travel history and symptoms, health care professionals suspected 2019-nCoV. A clinical specimen was collected and sent to CDC, where laboratory testing confirmed the infection. The Illinois Department of Public Health (IDPH) and the Chicago Department of Public Health (CDPH) are investigating locations where this patient went after returning to Illinois and are identifying any close contacts who were possibly exposed.  The patient has limited close contacts, all of whom are currently well and who will be monitored for symptoms. Since returning from China, the patient has had very limited movement outside the home.

CDC is taking aggressive public health measures to help protect the health of Americans.  While CDC considers this a serious public health threat, based on current information, the immediate health risk from 2019-nCoV to the general American public is considered low at this time.  CDC is working closely with the Illinois Department of Public Health, the Chicago Department of Public Health, and other local partners. A CDC team has been deployed to support the ongoing investigation.

However, CDC has been proactively preparing for the introduction of 2019-nCoV in the U.S. for weeks, including:

  • First alerting clinicians on January 8 to be on the look-out for patients with respiratory symptoms and a history of travel to Wuhan, China.
  • Developing guidance for clinicians for testing and management of 2019-nCoV, as well as guidance for home care of patients with 2019-nCoV.
  • Has developed a diagnostic test to detect this virus in clinical specimens. Currently, testing must take place at CDC, but CDC is preparing to share these test kits with domestic and international partners.
  • Implementing public health entry screening at Atlanta (ATL), Chicago (ORD), Los Angeles (LAX), New York (JFK), and San Francisco (SFO) airports.  CDC is currently evaluating the extent and duration of this enhanced screening.
  • CDC has activated its Emergency Operations Center to better provide ongoing support.

Coronaviruses are a large family of viruses, some causing respiratory illness in people and others circulating among animals including camels, cats and bats. Rarely, animal coronaviruses can evolve and infect people and then spread between people, such as has been seen with Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). Investigations are ongoing to learn more, but person-to-person spread of 2019-nCoV is occurring.

It is likely there will be more cases reported in the U.S. in the coming days and weeks. CDC will continue to update the public as circumstances warrant.  While the immediate risk of this new virus to the American public is believed to be low at this time, there are simple daily precautions that everyone should always take.  It is currently flu and respiratory disease season, and CDC recommends getting vaccinated, taking everyday preventive actions to stop the spread of germs, and taking flu antivirals if prescribed.  Right now, CDC recommends travelers avoid all nonessential travel to Wuhan, China. In addition, CDC recommends people traveling to China practice certain health precautions like avoiding contact with people who are sick and practicing good hand hygiene.

For more information about the current outbreak in China, visit https://www.cdc.gov/coronavirus/2019-ncov/index.html. For travel health information, visit https://wwwnc.cdc.gov/travel/notices/watch/pneumonia-china.

This information was originally published on CDC.gov

First Travel-related Case of 2019 Novel Coronavirus Detected in United States

The Centers for Disease Control and Prevention (CDC) today confirmed the first case of 2019 Novel Coronavirus (2019-nCoV) in the United States in the state of Washington. The patient recently returned from Wuhan, China, where an outbreak of pneumonia caused by this novel coronavirus has been ongoing since December 2019. While originally thought to be spreading from animal-to-person, there are growing indications that limited person-to-person spread is happening. It’s unclear how easily this virus is spreading between people.

The patient from Washington with confirmed 2019-nCoV infection returned to the United States from Wuhan on January 15, 2020. The patient sought care at a medical facility in the state of Washington, where the patient was treated for the illness. Based on the patient’s travel history and symptoms, healthcare professionals suspected this new coronavirus. A clinical specimen was collected and sent to CDC overnight, where laboratory testing yesterday confirmed the diagnosis via CDC’s Real time Reverse Transcription-Polymerase Chain Reaction (rRT-PCR) test.

CDC has been proactively preparing for the introduction of 2019-nCoV in the United States for weeks, including:

  • First alerting clinicians on January 8, 2020, to be on the look-out for patients with respiratory symptoms and a history of travel to Wuhan, China.
  • Developing guidance for clinicians for testing and management of 2019-nCoV, as well as guidance for home care of patients with 2019-nCoV.
  • Developing a diagnostic test to detect this virus in clinical specimens, accelerating the time it takes to detect infection. Currently, testing for this virus must take place at CDC, but in the coming days and weeks, CDC will share these tests with domestic and international partners
  • On January 17, 2020, CDC began implementing public health entry screening at San Francisco (SFO), New York (JFK), and Los Angeles (LAX) airports. This week CDC will add entry health screening at two more airports – Atlanta (ATL) and Chicago (ORD).
  • CDC has activated its Emergency Operations Center to better provide ongoing support to the 2019-nCoV response.

CDC is working closely with the state of Washington and local partners. A CDC team has been deployed to support the ongoing investigation in the state of Washington, including potentially tracing close contacts to determine if anyone else has become ill.

Coronaviruses are a large family of viruses, some causing respiratory illness in people and others circulating among animals including camels, cats and bats. Rarely, animal coronaviruses can evolve and infect people and then spread between people, such as has been seen with Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). When person-to-person spread has occurred with SARS and MERS, it is thought to happen via respiratory droplets with close contacts, similar to how influenza and other respiratory pathogens spread. The situation with regard to 2019-nCoV is still unclear. While severe illness, including illness resulting in several deaths, has been reported in China, other patients have had milder illness and been discharged. Symptoms associated with this virus have included fever, cough and trouble breathing.  The confirmation that some limited person-to-person spread with this virus is occurring in Asia raises the level of concern about this virus, but CDC continues to believe the risk of 2019-nCoV to the American public at large remains low at this time.

This is a rapidly evolving situation. CDC will continue to update the public as circumstances warrant.

For more information about the current outbreak in China, visit: https://www.cdc.gov/coronavirus/novel-coronavirus-2019.html

This information originally published on CDC.gov

Public Health Screening to Begin at 3 U.S. Airports for 2019 Novel Coronavirus (“2019-nCoV”)

The Centers for Disease Control and Prevention (CDC) and the Department of Homeland Security’s Customs and Border Protection (CBP) will implement enhanced health screenings to detect ill travelers traveling to the United States on direct or connecting flights from Wuhan, China. This activity is in response to an outbreak in China caused by a novel (new) coronavirus (2019 nCoV), with exported cases to Thailand and Japan.

Starting January 17, 2020, travelers from Wuhan to the United States will undergo entry screening for symptoms associated with 2019-nCoV at three U.S. airports that receive most of the travelers from Wuhan, China: San Francisco (SFO), New York (JFK), and Los Angeles (LAX) airports.

“To further protect the health of the American public during the emergence of this novel coronavirus, CDC is beginning entry screening at three ports of entry. Investigations into this novel coronavirus are ongoing and we are monitoring and responding to this evolving situation,” said Martin Cetron, M.D., Director of CDC’s Division of Global Migration and Quarantine.

Based on current information, the risk from 2019-nCoV to the American public is currently deemed to be low. Nevertheless, CDC is taking proactive preparedness precautions.

Entry screening is part of a layered approach used with other public health measures already in place to detect arriving travelers who are sick (such as detection and reporting of ill travelers by airlines during travel and referral of ill travelers arriving at a US port of entry by CBP) to slow and reduce the spread of any disease into the United States.

CDC is deploying about 100 additional staff to the three airports (SFO, JFK, and LAX) to supplement existing staff at CDC quarantine stations located at those airports.

CDC is actively monitoring this situation for pertinent information about the source of outbreak, and risk for further spread through person-to-person or animal-to-person transmission. CDC may adjust screening procedures and other response activities as this outbreak investigation continues and more is learned about the newly emerging virus. Entry screening alone is not a guarantee against the possible importation of this new virus but is an important public health tool during periods of uncertainty and part of a multilayered government response strategy. As new information emerges, CDC will reassess entry screening measures and could scale activities up or down accordingly.

On Jan. 11, 2020, CDC updated a Level 1 Travel Health Notice (“practice usual precautions”) for travelers to Wuhan City and an updated Health Alert to health care professionals and public health partners with new and updated guidance is forthcoming.

China health officials report that most of the patients infected with 2019-nCoV have had exposure to a large market where live animals were present, suggesting this is a novel virus that has jumped the species barrier to infect people. Chinese authorities additionally report that several hundred health care workers caring for outbreak patients are being monitored and no spread of this virus from patients to health care workers has been seen. They report no sustained spread of this virus in the community, however there are indications that some limited person-to-person spread may have occurred. CDC is responding to this outbreak out of an abundance of caution, ready to detect people infected with 2019-CoV.

For the latest information on the outbreak, visit CDC’s Novel Coronavirus 2019 website.

This information was originally published on CDC.gov